Article
Detection of Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma: Comparing Cobas 4800 EGFR Assay With Sanger Bidirectional Sequencing.
Clinical lung cancer - 1 Sept 2016
Ardakani Nima Mesbah, Giardina Tindaro, Grieu-Iacopetta Fabienne, Tesfai Yordanos, Carrello Amerigo, Taylor Jeremy, Robinson Cleo, Spagnolo Dominic, Amanuel Benhur
Abstract excerpt
INTRODUCTION: Accurate detection of epidermal growth factor receptor (EGFR) mutations has a crucial role in the current treatment of patients with lung adenocarcinoma, and identification of clinically relevant mutations would qualify patients for treatment with tyrosine kinase inhibitors. Historically, Sanger sequencing has been used as the reference standard assay for EGFR mutational analysis; however, Cobas...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
